A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B
Clinical trial NCT07190742 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07190742
- Sponsor
- Grand Theravac Life Sciences (Nanjing) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-10-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.